PERKINELMER INC.PERKINELMER INC.PERKINELMER INC.

PERKINELMER INC.

No trades
See on Supercharts
Market capitalization
‪11.53 B‬EUR
‪−107.25 M‬EUR
‪2.49 B‬EUR
‪123.05 M‬
Beta (1Y)
0.74

About PERKINELMER INC.

CEO
Prahlad Ramadhar Singh
Headquarters
Waltham
Employees (FY)
‪11.5 K‬
Founded
1937
ISIN
US7140461093
FIGI
BBG000FP1M16
Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. With a global network and localized agility, the company serves a diverse range of organizations from pharmaceutical and biotech to clinical labs, academia, and governments. It is headquartered in Waltham, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange PERKINELMER INC. stocks are traded under the ticker PKN.
PERKINELMER INC. is going to release the next earnings report on Apr 29, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for PERKINELMER INC. has a max estimate of 127.16 EUR and a min estimate of 94.19 EUR.
PKN earnings for the last quarter are 1.12 EUR per share, whereas the estimation was 1.13 EUR resulting in a −1.14% surprise. The estimated earnings for the next quarter are 1.06 EUR per share. See more details about PERKINELMER INC. earnings.
PERKINELMER INC. revenue for the last quarter amounts to ‪634.71 M‬ EUR despite the estimated figure of ‪657.84 M‬ EUR. In the next quarter revenue is expected to reach ‪613.49 M‬ EUR.
Yes, you can track PERKINELMER INC. financials in yearly and quarterly reports right on TradingView.
PKN net income for the last quarter is ‪93.07 M‬ EUR, while the quarter before that showed ‪9.04 M‬ EUR of net income which accounts for 929.60% change. Track more PERKINELMER INC. financial stats to get the full picture.
Yes, PKN dividends are paid quarterly. The last dividend per share was 0.07 EUR. As of today, Dividend Yield (TTM)% is 0.28%. Tracking PERKINELMER INC. dividends might help you take more informed decisions.
Like other stocks, PKN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PERKINELMER INC. stock right from TradingView charts — choose your broker and connect to your account.
PKN reached its all-time high on Jan 3, 2022 with the price of 179.15 EUR, and its all-time low was 4.40 EUR and was reached on Oct 18, 2002.
See other stocks reaching their highest and lowest prices.
As of Apr 20, 2024, the company has ‪11.50 K‬ employees. See our rating of the largest employees — is PERKINELMER INC. on this list?
We've gathered analysts' opinions on PERKINELMER INC. future price: according to them, PKN price has a max estimate of 127.16 EUR and a min estimate of 94.19 EUR. Read a more detailed PERKINELMER INC. forecast: see what analysts think of PERKINELMER INC. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PERKINELMER INC. EBITDA is ‪753.13 M‬ EUR, and current EBITDA margin is 30.22%. See more stats in PERKINELMER INC. financial statements.